Save Article

Chinese Drug Makers Feel Pain
Of Government Overhauls, Probe

For investors, the Chinese pharmaceuticals sector is as fraught with risk as it is full of promise. For now, the best investment prescription may be caution.

A spate of Chinese drug companies have listed shares in Hong Kong and New York this year, and more plan to follow. The activity underscores the companies' hunger for fresh capital and demand from overseas investors for more ways to play the Chinese market.